However, the lack of direct comparison between the incidence of PD in treated IBD patients compared with non-IBD patients (112) means that the ability of anti-TNF treatment to reduce PD incidence in non-IBD patients remains unanswered. This evidence concerns the gene TNF and Parkinson disease.